Found: 13
Select item for more details and to access through your institution.
Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Drug Exposure and Treatment Outcomes in Patients With Multidrug-Resistant Tuberculosis and Diabetes Mellitus: A Multicenter Prospective Cohort Study From China.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 524, doi. 10.1093/cid/ciae329
- By:
- Publication type:
- Article
Drug Exposure and Minimum Inhibitory Concentration Predict Pulmonary Tuberculosis Treatment Response.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3520, doi. 10.1093/cid/ciaa1569
- By:
- Publication type:
- Article
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. e3511, doi. 10.1093/cid/ciaa1509
- By:
- Publication type:
- Article
Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 8, p. 1394, doi. 10.1093/cid/ciy1068
- By:
- Publication type:
- Article
A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 6, p. 820, doi. 10.1093/infdis/jiad007
- By:
- Publication type:
- Article
Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1022090
- By:
- Publication type:
- Article
Salivary Therapeutic Drug Monitoring of Antimicrobial Therapy: Feasible or Futile?
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 3, p. 269, doi. 10.1007/s40262-024-01346-7
- By:
- Publication type:
- Article
Drug exposure of first‐line anti‐tuberculosis drugs in China: A prospective pharmacological cohort study.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1347, doi. 10.1111/bcp.14522
- By:
- Publication type:
- Article
Individualised dosing algorithm and personalised treatment of high‐dose rifampicin for tuberculosis.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 10, p. 2341, doi. 10.1111/bcp.14048
- By:
- Publication type:
- Article
A modeling‐based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 5, p. 628, doi. 10.1002/psp4.12768
- By:
- Publication type:
- Article
New Oxazolidinones for Tuberculosis: Are Novel Treatments on the Horizon?
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 818, doi. 10.3390/pharmaceutics16060818
- By:
- Publication type:
- Article
Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 1, p. 144, doi. 10.3390/pharmaceutics16010144
- By:
- Publication type:
- Article